|
|
|
Volumn 20, Issue 5 Suppl 2, 2006, Pages 35-40
|
|
Nondermatologic adverse events associated with anti-EGFR therapy.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
CETUXIMAB;
DRUG DERIVATIVE;
ENZYME INHIBITOR;
EPIDERMAL GROWTH FACTOR RECEPTOR;
GEFITINIB;
IRINOTECAN;
MONOCLONAL ANTIBODY;
PROTEIN TYROSINE KINASE;
QUINAZOLINE DERIVATIVE;
CHEMICALLY INDUCED DISORDER;
DRUG ANTAGONISM;
ENZYMOLOGY;
HUMAN;
INTERSTITIAL LUNG DISEASE;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
REVIEW;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
CAMPTOTHECIN;
CARCINOMA, NON-SMALL-CELL LUNG;
ENZYME INHIBITORS;
HUMANS;
LUNG DISEASES, INTERSTITIAL;
LUNG NEOPLASMS;
PROTEIN-TYROSINE KINASES;
QUINAZOLINES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
|
|
EID: 33750122183
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (36)
|
|
References (63)
|
